Termination of midgestation pregnancy using laminaria or intracervical prostaglandin E(2) followed by prostaglandin analogues

Cover Page


Cite item

Full Text

Abstract

Objective: The optimal regimen of medical termination of the second trimester pregnancy is still under development, but it likely to be characterized by a short induction-to-abortion interval, low incidence of side-effects and high acceptability.

Full Text

Objective: The optimal regimen of medical termination of the second trimester pregnancy is still under development, but it likely to be characterized by a short induction-to-abortion interval, low incidence of side-effects and high acceptability.

Methods: We conducted a prospective, randomized trial to evaluate the efficacy and safety of prostaglandin E2 and F2 alpha analogues intramuscular administration for second-trimester abortion in women intracervically pretreated with prostaglandin E2 (dinoprostone) gel (was given 12 hours before the intramuscular administration of prostaglandins) or one or more medium-thick laminaria tents (were used in a single application for 12 hours).

Results: 250 women requesting termination of second trimester pregnancy were randomized into 4 groups depending on different drug combinations. The mean age and parity of the women and the mean gestational age of the 4 groups were comparable. The median abortion interval was 8.2 hours and the cumulative abortion rates at 24 h was 95%. The total dose of the prostaglandins required to induce abortion and the incidence of side effects or analgesic requirement were significantly less due to cervical priming.

Conclusion: Combination of dinoprostone or laminaria priming of the cervix prior to the synthetic prostaglandin administration is an easy, practical, reliable and safe method of pregnancy termination in midgestation.

×

About the authors

N. F. Kravchenko

Research Centre of Obstetrics, Gynecology & Perinatology

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Moscow

B. L. Gurtovoi

Research Centre of Obstetrics, Gynecology & Perinatology

Email: info@eco-vector.com
Russian Federation, Moscow

N. V. Ordzhonikidze

Research Centre of Obstetrics, Gynecology & Perinatology

Email: info@eco-vector.com
Russian Federation, Moscow

V. L. Tioutiounnik

Research Centre of Obstetrics, Gynecology & Perinatology

Email: info@eco-vector.com
Russian Federation, Moscow

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 1999 Eсо-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies